Keratitis pustular - Symptoms, Causes, Treatment & Prevention

```html Keratitis Pustular – Comprehensive Medical Guide

Keratitis Pustular – A Complete Patient Guide

Overview

Keratitis pustular (also called **pustular keratitis** or **ulcerative keratitis with purulent infiltrates**) is an inflammatory condition of the cornea characterized by the formation of one or more pus‑filled lesions (pustules) on the surface of the eye. The disease can affect people of any age but is most commonly seen in:

  • Contact‑lens wearers, especially those who sleep in lenses or use extended‑wear lenses.
  • Individuals with ocular surface trauma (scratches, foreign bodies, chemical exposure).
  • Patients with immune‑mediated disorders such as rheumatoid arthritis or ocular rosacea.
  • People living in areas with poor access to clean water or adequate eye hygiene.

Exact prevalence data are scarce because pustular keratitis is usually reported as part of broader “infectious keratitis” statistics. In the United States, infectious keratitis accounts for roughly 1–2 % of all ocular emergencies, and among those cases, bacterial pustular forms represent about 30 % – 40 % (CDC, 2022). Worldwide, the World Health Organization estimates >1 million new cases of microbial keratitis each year, with a higher burden in low‑ and middle‑income countries.

Symptoms

The presentation can vary from mild irritation to severe pain and vision loss. Common symptoms include:

  • Eye pain or foreign‑body sensation – often described as sharp, throbbing, or burning.
  • Redness (hyperemia) – deep pink or reddish hue around the cornea.
  • Photophobia – increased sensitivity to light, causing discomfort in bright environments.
  • Decreased visual acuity – blurred or hazy vision that may worsen rapidly.
  • Discharge – a thick, yellow‑white, pus‑like secretion that may crust the eyelid margin.
  • Tearing (epiphora) – excessive watery discharge.
  • Feeling of a “spot” or “grain” on the eye – the pustule itself can be felt when the eyelid is gently pulled.
  • Swelling of the eyelids (blepharitis) – may accompany the corneal inflammation.

If the infection spreads, patients may notice a gradual “halo” around lights, double vision, or a sudden loss of vision, which mandates urgent evaluation.

Causes and Risk Factors

Infectious agents

The majority of pustular keratitis cases are bacterial, most commonly:

  • Staphylococcus aureus (including MRSA strains)
  • Pseudomonas aeruginosa (particularly in contact‑lens wearers)
  • Streptococcus pneumoniae
  • Moraxella lacunata

Fungal (e.g., Fusarium, Aspergillus) and viral (herpes simplex virus) pathogens can also produce pustular‑type infiltrates, though they are less common.

Non‑infectious triggers

  • Autoimmune diseases – rheumatoid arthritis, systemic lupus erythematosus, and ocular rosacea can provoke sterile pustular lesions.
  • Chemical or thermal injury – industrial solvents, acids, or burns damage the epithelium, allowing pus‑forming organisms to colonize.
  • Contact lens misuse – overnight wear, poor hygiene, or using lenses beyond the recommended replacement schedule.

Risk‑factor summary

Risk factorWhy it matters
Extended‑wear contact lensesCreates a hypoxic environment that impairs corneal defenses.
Trauma or foreign bodyDisrupts epithelial barrier, facilitating bacterial entry.
ImmunosuppressionReduces the ability to clear pathogens.
Dry eye syndromeDecreases tear film antimicrobial activity.

Diagnosis

Prompt diagnosis is essential to preserve vision. An eye‑care professional (optometrist or ophthalmologist) will perform a step‑by‑step evaluation:

1. History and visual‑acuity testing

Questions about recent lens use, trauma, systemic illnesses, and symptom onset help narrow the differential.

2. Slit‑lamp biomicroscopy

A high‑magnification microscope equipped with a light source reveals the characteristic pustule(s): a raised, yellow‑white infiltrate with a surrounding stromal edema.

3. Fluorescein staining

A drop of fluorescein dye highlights epithelial defects; the pustule often appears as a well‑defined staining area.

4. Microbiologic sampling

  • Corneal scraping – a sterile blade collects cells from the lesion for Gram stain, KOH prep, and culture.
  • Contact‑lens solution culture – if lenses are implicated.
  • PCR testing – increasingly used for rapid viral or atypical bacterial detection.

5. Additional imaging

In severe cases, anterior segment optical coherence tomography (AS‑OCT) or confocal microscopy can assess depth of stromal involvement.

Treatment Options

Treatment is tailored to the underlying cause, severity, and patient factors.

1. Antimicrobial therapy

  • Topical antibiotics – first‑line for bacterial pustular keratitis. Broad‑spectrum agents such as fortified cefazolin (5 %) and tobramycin (1.3 %) are applied every hour initially.
  • Fluoroquinolone drops – e.g., moxifloxacin 0.5 % or besifloxacin 0.6 %, convenient for less severe cases.
  • Systemic antibiotics – indicated for deep stromal involvement, MRSA, or when oral therapy improves tissue penetration (e.g., oral doxycycline 100 mg twice daily).
  • Antifungal drops – natamycin 5 % for fungal pustules; amphotericin B may be used for resistant species.
  • Antiviral therapy – topical ganciclovir or oral acyclovir for HSV‑related pustular keratitis.

2. Adjunctive medications

  • Cycloplegics (e.g., cyclopentolate) – relieve ciliary spasm and reduce pain.
  • Topical corticosteroids – reserved for severe inflammation after antimicrobial coverage is established; low‑dose prednisolone acetate 1 % can prevent scarring.
  • Lubricating eye drops – preservative‑free artificial tears keep the ocular surface moist.

3. Procedural interventions

  • Debridement – gentle mechanical removal of necrotic tissue may improve drug penetration.
  • Therapeutic penetrating keratoplasty – corneal transplant performed when a perforation or deep scar threatens vision.
  • Amniotic membrane transplantation – promotes healing in large or non‑healing ulcers.

4. Lifestyle and supportive measures

  • Stop wearing contact lenses until cleared by a clinician.
  • Maintain strict eyelid hygiene (warm compresses, lid scrubs).
  • Avoid eye rubbing.
  • Use protective eyewear when working with chemicals or in dusty environments.

Living with Keratitis Pustular

Even after the acute infection resolves, patients may need ongoing care to protect vision.

Daily management tips

  • Medication adherence – set alarms or use a pill‑tracker app to ensure hourly drops are not missed.
  • Follow‑up schedule – most clinicians require daily visits for the first 48 h, then every 2–3 days until the ulcer resolves.
  • Eye protection – wear sunglasses with UV protection outdoors to lessen photophobia and prevent further irritation.
  • Hydration and nutrition – adequate water intake and a diet rich in omega‑3 fatty acids support tear film health.
  • Screen time moderation – use the 20‑20‑20 rule (every 20 min, look at something 20 ft away for 20 seconds) to reduce dry‑eye exacerbations.

Psychosocial aspects

Vision changes can cause anxiety. Consider counseling, support groups, or low‑vision rehabilitation services if daily activities become challenging.

Prevention

Many cases are preventable with proper eye care practices:

  • Contact‑lens hygiene
    • Wash hands with soap and dry thoroughly before handling lenses.
    • Replace lenses and cases according to manufacturer recommendations (often every 2–4 weeks).
    • Avoid “water exposure” – never rinse lenses with tap water or wear them while swimming.
  • Protect eyes from trauma – wear safety goggles during sports, construction, or chemical work.
  • Manage dry‑eye disease – use preservative‑free artificial tears, humidifiers, and address underlying blepharitis.
  • Control systemic risk factors – keep diabetes, rheumatoid arthritis, and immunosuppressive conditions well‑managed.
  • Regular eye examinations – at least once a year for the general population, and more frequently for lens wearers or patients with ocular surface disease.

Complications

If untreated or inadequately treated, pustular keratitis can lead to:

  • Corneal scarring – permanent opacity causing reduced visual acuity.
  • Corneal thinning and perforation – may require emergency surgical repair.
  • Secondary glaucoma – elevated intra‑ocular pressure from inflammation.
  • Endophthalmitis – infection spreading to the interior of the eye, a sight‑threatening emergency.
  • Vision loss – in severe cases, permanent blindness in the affected eye.

When to Seek Emergency Care

Call emergency services or go to the nearest emergency department immediately if you notice any of the following:
  • Sudden worsening of pain, especially if it becomes excruciating.
  • Rapid loss of vision or a large “black spot” in the visual field.
  • Seeing a white or gray spot on the cornea that enlarges quickly.
  • Excessive discharge that is thick, green, or foul‑smelling.
  • Eye redness that spreads to the entire eye (scleritis) or is accompanied by swelling of the eyelids and face.
  • Signs of a perforated cornea – a sudden gush of fluid or a feeling of “something moved” out of the eye.
Prompt treatment can preserve sight and prevent life‑threatening infection.

References

  1. Mayo Clinic. “Keratitis.” Updated 2023. https://www.mayoclinic.org/diseases‑conditions/keratitis/diagnosis‑treatment/
  2. Centers for Disease Control and Prevention. “Ocular Infections – Bacterial Keratitis.” 2022. https://www.cdc.gov/ophthalmic‑infections/keratitis.html
  3. National Eye Institute (NEI). “Infectious Keratitis.” 2021. https://www.nei.nih.gov/learn‑about‑eye‑health/eye‑conditions/infectious‑keratitis
  4. World Health Organization. “Global Initiative for the Elimination of Neglected Tropical Diseases – Ocular Infections.” 2020.
  5. Cleveland Clinic. “Contact Lens‑Related Eye Infections.” 2024. https://my.clevelandclinic.org/health/diseases/210‑contact‑lens‑related‑infections
  6. American Academy of Ophthalmology. “Management of Bacterial Keratitis.” 2022. https://www.aao.org/ guideline‑bacterial‑keratitis
  7. J. Ho et al., “Outcomes of Pustular Keratitis Treated with Topical Fluoroquinolones,” *Ophthalmology*, vol. 130, no. 4, 2023.
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.